Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence

Hach, T; Shakeri-Nejad, K; Bigaud, M; Dahlke, F; de Micco, M; Petricoul, O; Graham, G; Piani-Meier, D; Turrini, R; Brinkmann, V; Nicoletti, F

Hach, T (通讯作者)，Novartis Pharm AG, Patient Engagement, Basel, Switzerland.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2023; 43 (6): 246

Abstract

Maladjusted immune responses to the coronavirus disease 2019 (COVID-19), for example, cytokine release syndrome, may result in immunopathology and acu......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索